Amplify Partners led a $30m round in Tahoe Therapeutics.

Amplify Partners, a venture capital firm, led a $30m round in Tahoe Therapeutics, a biotechnology company, with participation from Databricks Ventures, Wing Venture Capital, General Catalyst, Civilization Ventures, Conviction, Mubadala Capital Ventures and AIX Ventures. "While structural models have accelerated molecular design, they rarely translate to clinical success — a problem that remains one of the biggest challenges in drug development. Tahoe Therapeutics is uniquely positioned to move the industry past this bottleneck by generating massive drug-patient datasets and training high-dimensional, cell-based AI models. We’re proud to back this exceptional team as they combine biology and computation to accelerate clinical impact," Sunil Dhaliwal, Amplify Partners General Partner.